CAH
Cardinal Health Inc
NYSE: CAH · HEALTHCARE · MEDICAL DISTRIBUTION
$234.57
-0.61% today
Updated 2026-09-11
Market cap
$55.93B
P/E ratio
33.31
P/S ratio
0.22x
EPS (TTM)
$7.22
Dividend yield
0.83%
52W range
$144 – $258
Volume
1.9M
WallStSmart proprietary scores
55
out of 100
Grade: C+
Hold
Investment rating
7.3
Growth
B+7.0
Quality
B+4.5
Profitability
C4.0
Valuation
C5/9
Piotroski F-Score
Moderate
4.5
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →251 stocks currently score above 75
Price targets
Analyst target
$230.45
-1.76%
12-Month target
$207.60
-11.50%
Intrinsic (DCF)
$175.16
Margin of safety
-37.02%
Price chart
Stock snapshot
Strengths
+ Altman Z 4.52 — safe zone
+ Free cash flow $1.43B — positive
+ Debt/equity -3.45x — low leverage
Risks
- Thin margins at 0.67%
- 37.02% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2023 | 2024 | 2025 | 2026 | TTM | 2027 (E) |
|---|---|---|---|---|---|---|
| Revenue | $204.98B | $226.83B | $222.58B | $254.25B | $254.25B | $284.8B |
| Net income | $330.00M | $852.00M | $1.56B | $1.71B | $394.00M | — |
| EPS | — | — | — | — | $7.22 | $11.69 |
| Free cash flow | $2.36B | $3.25B | $1.85B | $4.53B | $1.43B | — |
| Profit margin | 0.16% | 0.38% | 0.70% | 0.67% | 0.67% | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-08-19 | SCHERER, MARY C. | Sale | 2,202 | $237.39 |
| 2026-08-19 | SCHERER, MARY C. | Sale | 100 | $237.40 |
| 2026-08-19 | HOLLAR, JASON M. | Sale | 16,187 | $237.23 |
Peer comparison
Smart narrative
Cardinal Health Inc trades at $234.57. representing a P/E of 33.31x trailing earnings. Our Smart Value Score of 55/100 indicates the stock is fair. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 4.52, it sits in the safe zone. TTM revenue stands at $254.25B. with profit margins at 0.67%. Our DCF model estimates intrinsic value at $175.16.
Frequently asked questions
What is Cardinal Health Inc's stock price?
Cardinal Health Inc (CAH) trades at $234.57, on a P/E of 33.3x and a P/S of 0.2x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Cardinal Health Inc overvalued?
Cardinal Health Inc carries a Smart Value Score of 55/100 (Grade C+), which we rate Hold. That score blends growth, quality, and valuation into one read. On valuation specifically, our conservative DCF puts intrinsic value at $175.16 against the $234.57 price, so on cash flow terms the market is paying a premium for Cardinal Health Inc's growth. The Hold rating reflects that growth and quality, while the DCF flags that the price already assumes a lot.
What is the price target of Cardinal Health Inc (CAH)?
The 12-month analyst consensus target is $230.45, about 1.8% below the current $234.57. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the future stock price of CAH by 2030?
Our research-backed model puts the 2030 base case at $18,344.09, built from revenue projections, a growth-adjusted P/S multiple, net debt, and share dilution. It is a scenario rather than a prediction, and the bull and bear cases around it matter more than the single number when you are sizing a position.
What is the intrinsic value of Cardinal Health Inc (CAH)?
Our DCF model estimates intrinsic value at $175.16, a -37.0% margin of safety versus today's $234.57. Intrinsic value is what the projected cash flows are worth today. A negative reading means the price is running ahead of that conservative estimate, leaving little downside cushion if growth slows.
What is Cardinal Health Inc's revenue?
Cardinal Health Inc's trailing twelve-month revenue is $254.25B, and our model projects it reaching about $359.68B by 2030. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Cardinal Health Inc's Altman Z-Score is 4.52, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL DISTRIBUTION
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.22x
ROE—
Beta0.52
50D MA$234.23
200D MA$215.76
Shares out0.23B
Float0.23B
Short ratio—
Avg volume1.9M
Performance
1 week-5.10%
1 month-0.26%
3 months+3.61%
YTD+14.15%
1 year+54.08%
3 years—
5 years—